24/7 Market News - Kraig Labs Working to Make Spider Silk a Once-in-a-Generation Technological Breakthrough
DENVER, Oct. 14, 2025 (GLOBE NEWSWIRE) -- All the buzz around technology today is centered on Artificial Intelligence, Robotics, Digital Currency ($BTC), and the rare earth minerals used to build them. However, these innovations, as impressive as they are, represent just the continued story arc of the Internet of Things’ drive to connect and digitize everything on the planet.
While these technologies will undoubtedly open new frontiers, nothing in materials science is more exciting than the upcoming commercialization of spider silk, and the groundbreaking advancements made by Kraig Biocraft Laboratories (OTCQB: KBLB) to bring this super fiber to market.
Who would have believed, back when we were watching Spider-Man as kids, that one day real scientists would use CRISPR-like gene editing to transfer spider DNA into silkworms creating transgenic silkworms capable of producing authentic spider silk?
By implanting key spider DNA sequences into the silkworm genome, Kraig Labs has turned one of nature’s most efficient fiber producers into a biological factory for a biodegradable super fiber five times tougher than steel by weight, way more flexible than Kevlar, and fully sustainable.
Not since Kevlar revolutionized materials science in the 1970s has a true “super fiber” shown the potential to reach global commercial scale until now. Kraig’s spider silk stands at a similar place, as it looks to enter the market. It’s also natural, renewable, and biodegradable. It merges the strength and elasticity of spider silk with the scalability of silkworm production, now measured in metric tons.
Kraig has already announced pending commercial sales orders, which it is actively working to fulfill. Production is underway using its proprietary BAM-1 hybrids as the company continues expanding operations. Recent press releases confirmed that Kraig has been preparing an order from an elite European luxury fashion house. Kraig also continues discussions with both a top-tier performance sportswear brand and a leading athletic equipment manufacturer, signaling broad interest across industries.
With two operational rearing facilities in Southeast Asia and a third location now being finalized, Kraig Labs continues to expand its global footprint to meet rising demand. Each site is designed for continuous rearing cycles, ensuring scalability, redundancy, and consistent material output.
Now, in the fourth quarter, investors are watching closely as the company moves to complete these initial orders, a milestone that would mark what we believe to be the first commercial scale sale of quality mass produced spider silk in human history.
This breakthrough has the potential to redefine multiple industries at once from high-performance apparel and aerospace composites to medical sutures, ballistics, and many more.
For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com
Please click here to read the full Kraig Labs analyst report on 247marketnews.com.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) is a biotechnology company focused on the development and commercialization of spider silk-based fiber technologies. Through its proprietary silkworm-based genetic engineering platform, Kraig Labs produces high-performance, cost-effective, and scalable spider silk materials for use in defense, performance apparel, technical textiles, and medical applications.
For more information, please visit: www.kraiglabs.com
Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.
About 24/7 Market News
24/7 Market News (247) is a leading market news platform for public companies. As a pioneer in digital media, 247 is dedicated to the swift distribution of financial market news and information. 247 takes great pride in creating innovative public relations campaigns that help clients reach the target audience.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by one or more featured companies for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/kblb-disclosure/ for further KBLB and 247marketnews.com disclosure information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
